NFE2L2 and neoplasm: In tumor cells with low Nrf2-antioxidant response after treatment, the levels of reactive oxygen species remain high, H2AX is efficiently degraded, further reducing repair of DNA damage induced by the drug, tumor cell apoptosis is subsequently increased, and patient survival improved (Gruosso et al. 2016).